Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation
일자:
정렬 기준:
 검색 관련기사 보기:LSE:CRTX
일자시간출처헤드라인심볼기업
2024/06/0323:25RNS Regulatory NewsCrism Therapeutics Corporation Director DealingLSE:CRTXCrism Therapeutics Corporation
2024/06/0105:58Alliance NewsAlliance NewsIN BRIEF: Crism has first day of trade on AIM after name change, buyLSE:CRTXCrism Therapeutics Corporation
2024/05/3115:00RNS Regulatory NewsCrism Therapeutics Corporation Admission to Trading and First Day of DealingsLSE:CRTXCrism Therapeutics Corporation
2009/12/1903:45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010LSE:CRTX
2009/11/2105:40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalLSE:CRTX
2009/11/1622:00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceLSE:CRTX
2009/11/1322:00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselLSE:CRTX
2009/11/0421:00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsLSE:CRTX
2009/10/2121:00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallLSE:CRTX
2009/09/0321:01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)LSE:CRTX
2009/09/0321:00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesLSE:CRTX
2009/07/2021:00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalLSE:CRTX
2009/07/1608:04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductLSE:CRTX
2009/07/0905:15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tLSE:CRTX
2009/06/1305:35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsLSE:CRTXCornerstone Therapeutics Inc.
2009/06/1304:28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsLSE:CRTXCornerstone Therapeutics Inc.
2009/05/2005:01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeLSE:CRTX
2009/05/0720:01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpALSE:CRTX
2009/05/0720:00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsLSE:CRTX
2009/04/2721:00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallLSE:CRTX
2009/01/1407:33Dow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesLSE:CRTXCornerstone Therapeutics Inc.
2009/01/1405:34Dow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesLSE:CRTXCornerstone Therapeutics Inc.
2008/11/0522:00PR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsLSE:CRTX
2006/08/0123:00PR Newswire (US)Critical Therapeutics Files Controlled Release Formulation of ZileutonLSE:CRTX
 검색 관련기사 보기:LSE:CRTX